CME Group Inc. (NASDAQ:CME) Shares Acquired by Fidelis Capital Partners LLC

Fidelis Capital Partners LLC lifted its stake in shares of CME Group Inc. (NASDAQ:CME) by 19.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,675 shares of the financial services provider’s stock after acquiring an additional 275 shares during the quarter. Fidelis Capital Partners LLC’s holdings in CME Group were worth $353,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the stock. Capital Advisors Ltd. LLC increased its stake in shares of CME Group by 5.0% during the third quarter. Capital Advisors Ltd. LLC now owns 1,032 shares of the financial services provider’s stock valued at $207,000 after acquiring an additional 49 shares during the period. West Family Investments Inc. increased its stake in shares of CME Group by 3.4% during the second quarter. West Family Investments Inc. now owns 1,503 shares of the financial services provider’s stock valued at $278,000 after acquiring an additional 50 shares during the period. Jaffetilchin Investment Partners LLC increased its stake in shares of CME Group by 1.7% during the third quarter. Jaffetilchin Investment Partners LLC now owns 3,022 shares of the financial services provider’s stock valued at $605,000 after acquiring an additional 51 shares during the period. Thrivent Financial for Lutherans grew its position in CME Group by 0.3% in the second quarter. Thrivent Financial for Lutherans now owns 15,841 shares of the financial services provider’s stock worth $3,243,000 after buying an additional 52 shares during the last quarter. Finally, KC Investment Advisors LLC grew its position in CME Group by 1.7% in the first quarter. KC Investment Advisors LLC now owns 3,343 shares of the financial services provider’s stock worth $795,000 after buying an additional 55 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

CME has been the topic of several recent research reports. Rosenblatt Securities restated a “sell” rating and issued a $180.00 price target on shares of CME Group in a research report on Thursday, January 4th. Argus lifted their price target on shares of CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $210.00 price target (down previously from $235.00) on shares of CME Group in a research report on Friday, April 5th. Barclays lifted their price target on shares of CME Group from $225.00 to $226.00 and gave the stock an “equal weight” rating in a research report on Monday, April 8th. Finally, The Goldman Sachs Group lowered shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 price target on the stock. in a research report on Wednesday, January 3rd. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $215.70.

CME Group Trading Up 1.6 %

CME Group stock opened at $213.04 on Friday. The company has a 50 day moving average price of $214.42 and a 200 day moving average price of $211.70. The firm has a market capitalization of $76.69 billion, a price-to-earnings ratio of 24.02, a P/E/G ratio of 5.94 and a beta of 0.49. CME Group Inc. has a 52 week low of $175.73 and a 52 week high of $223.80. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.27 by $0.10. The company had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.43 billion. CME Group had a net margin of 57.83% and a return on equity of 12.32%. The company’s revenue for the quarter was up 19.2% on a year-over-year basis. During the same quarter last year, the business posted $1.92 EPS. Research analysts forecast that CME Group Inc. will post 9.57 EPS for the current year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Shareholders of record on Friday, March 8th were paid a dividend of $1.15 per share. The ex-dividend date of this dividend was Thursday, March 7th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.16%. This is a positive change from CME Group’s previous quarterly dividend of $1.10. CME Group’s dividend payout ratio (DPR) is 51.86%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.